Skip to main content
. 2021 Jan 28;13(1):32–45. doi: 10.3390/neurolint13010004
CGRP Calcitonin gene-related peptide
5-HT 5-hydroxytryptamine
PACAP Pituitary adenylate cyclase activating polypeptide
NSAIDs non-steroidal anti-inflammatory drugs
IV intravenous
CBT Cognitive Behavioral Therapy
nVNS Non-invasive vagal nerve stimulation
TMS transcranial magnetic stimulation
ONS occipital nerve stimulation
SMS supraorbital transcutaneous stimulation
BT-A botulinum toxin A
CYP3A4 Cytochrome P450 3A4
BCRP breast cancer resistance protein
P-glycoprotein P-gp
TEAEs treatment-emergent adverse events
AEs adverse events
ALT alanine aminotransferase
AST aspartate aminotransferase